fda compounding glp-1 enforcement news november 2025 Diabetes advocacy group discourages use of compounded drugs FDA Moves to Restrict Mass-Marketed

The growth is exciting because it provides more options to tailor treatment to an individuals health needs. We talked to obesity medicine experts about what new medications theyre excited about and what all this innovation means for the future of weight care

Do I earn them back

The success of GLP-1 medications has reduced the use of bariatric surgery for major weight loss by 140%, according to a Harvard University School of Public Health study of insurance claims from 2022-2024

Some people report mild digestive discomfort, particularly when starting at higher doses

What will happen if you stop injecting Glutathione

Amyloid & tau modulation : In mouse models of AD, GLP-1 RAs reduce amyloid oligomer levels and plaque load